In this blog I want to tell the story of the pharmaceutical world. I will not just through my post, but also pointing out the major news affecting the industry and especially with the help of the many posts that I send
An FDA advisory committee voted 6–1 last week against recommending premarket approval (PMA) of Stryker Biotech’s OP-1 putty for use in an expanded patient population. The Orthopedic and Rehabilitation Devices Advisory Committee cited lingering concerns of whether the device promoted bone growth and pointed to safety issues regarding immunogenicity and maternal and fetal antibody transfer.
